# Transcode Therapeutics, Inc.: Form 8-K, filed Oct 3, 2025

- Company: [Transcode Therapeutics, Inc.](/companies/rnaz.md) (CIK 1829635)
- Form: 8-K
- Filed: 2025-10-03
- Accepted by EDGAR: Oct 3, 2025, 20:15 ET
- Period: 2025-09-30
- Accession: 0001104659-25-096658
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829635/000110465925096658/tm2527978d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829635/000110465925096658/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829635/000110465925096658/tm2527978d1_8k.htm

Filed Oct 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-096658. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
